Free Trial
NASDAQ:NMTC

NeuroOne Medical Technologies (NMTC) Stock Price, News & Analysis

NeuroOne Medical Technologies logo
$0.71 -0.04 (-5.00%)
Closing price 07/11/2025 03:58 PM Eastern
Extended Trading
$0.73 +0.02 (+2.39%)
As of 07/11/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NeuroOne Medical Technologies Stock (NASDAQ:NMTC)

Key Stats

Today's Range
$0.71
$0.75
50-Day Range
$0.56
$0.75
52-Week Range
$0.40
$1.39
Volume
90,970 shs
Average Volume
188,363 shs
Market Capitalization
$35.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.45
Consensus Rating
Buy

Company Overview

NeuroOne Medical Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

NMTC MarketRank™: 

NeuroOne Medical Technologies scored higher than 55% of companies evaluated by MarketBeat, and ranked 508th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    NeuroOne Medical Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    NeuroOne Medical Technologies has only been the subject of 1 research reports in the past 90 days.

  • Read more about NeuroOne Medical Technologies' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NeuroOne Medical Technologies is -3.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NeuroOne Medical Technologies is -3.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    NeuroOne Medical Technologies has a P/B Ratio of 23.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about NeuroOne Medical Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    0.23% of the float of NeuroOne Medical Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    NeuroOne Medical Technologies has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeuroOne Medical Technologies has recently decreased by 44.89%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    NeuroOne Medical Technologies does not currently pay a dividend.

  • Dividend Growth

    NeuroOne Medical Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.23% of the float of NeuroOne Medical Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    NeuroOne Medical Technologies has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeuroOne Medical Technologies has recently decreased by 44.89%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    NeuroOne Medical Technologies has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for NeuroOne Medical Technologies this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added NeuroOne Medical Technologies to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NeuroOne Medical Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,569.00 in company stock.

  • Percentage Held by Insiders

    Only 8.90% of the stock of NeuroOne Medical Technologies is held by insiders.

  • Percentage Held by Institutions

    Only 16.07% of the stock of NeuroOne Medical Technologies is held by institutions.

  • Read more about NeuroOne Medical Technologies' insider trading history.
Receive NMTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

NMTC Stock News Headlines

NeuroOne Medical Technologies Corporation (NMTC) - Yahoo Finance
Top 5 Stocks Under $5 You Can’t Miss
5 Best Cheap Stocks Under $5! Ready to discover hidden gems in the stock market? 📈 Download our free report featuring 5 top stocks trading under $5 with massive growth potential.
See More Headlines

NMTC Stock Analysis - Frequently Asked Questions

NeuroOne Medical Technologies' stock was trading at $0.8259 at the start of the year. Since then, NMTC shares have decreased by 13.8% and is now trading at $0.7120.

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) posted its earnings results on Tuesday, May, 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.09) by $0.02. The company had revenue of $1.39 billion for the quarter, compared to analysts' expectations of $1.27 billion. NeuroOne Medical Technologies had a negative trailing twelve-month return on equity of 334.64% and a negative net margin of 75.41%.
Read the conference call transcript
.

Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroOne Medical Technologies investors own include Schwab US Large-Cap ETF (SCHX), NVIDIA (NVDA), Advanced Micro Devices (AMD), NIO (NIO), Ford Motor (F), Meta Platforms (META) and Plug Power (PLUG).

Company Calendar

Last Earnings
5/13/2025
Today
7/13/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NMTC
CIK
1500198
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$1.45
Low Price Target
$1.45
Potential Upside/Downside
+103.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.32 million
Net Margins
-75.41%
Pretax Margin
-75.40%
Return on Equity
-334.64%
Return on Assets
-124.42%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.13
Quick Ratio
1.09

Sales & Book Value

Annual Sales
$5.76 million
Price / Sales
6.16
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.03 per share
Price / Book
23.73

Miscellaneous

Outstanding Shares
49,818,000
Free Float
45,384,000
Market Cap
$35.47 million
Optionable
Optionable
Beta
0.66
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:NMTC) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners